Thursday Apr 17
StemCells Inc. Completes Enrollment In Spinal Cord Injury Trial
StemCells, Inc. announced today that it has completed enrollment in the Company's Phase I/II clinical trial in spinal cord injury.
BioTime Joins Advanced Cell Technology In The AMD Race
Advanced Cell Technology is leading the race with an ongoing Phase I trial, while BioTime is still preparing an IND for submission to the FDA.
StemCells Inc. To Participate At The 13th Annual Healthcare Conference
StemCells, Inc. announced today that management will present at the 13th Annual Needham Healthcare Conference, on Wednesday, April 9, at 8:40 AM EDT at the Westin Grand Central Hotel, 212 East 42nd Street, in New York City.